Skip to main content
Displaying 1 - 12 of 38
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Pathophysiological analysis of MASH: targetting clinical manifestations
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Approaching MASH as a metabolic disease with the need for holistic therapy
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Discussion
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and Closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
General Hepatology
First line assessment of liver steatosis with ultrasound: the qualitative gold standard becomes quantitative and multiparametr...
Webcasts
View
General Hepatology
E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” (Complete Session)
Webcasts
View
General Hepatology
Introduction
Webcasts
View
General Hepatology
2D-TE with point of care ultrasound imaging: a robust and reliable alternative for liver stiffness measurement
Webcasts
View
General Hepatology
Meet one of the inventors of transient elastography: a 20-year journey of research and innovations in liver stiffness measurem...
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy